Insider Selling: Adtalem Global Education (NYSE:CVSA) CEO Sells $330,742.62 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,529 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $130.78, for a total value of $330,742.62. Following the completion of the transaction, the chief executive officer owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. This represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 0.1%

CVSA stock opened at $128.23 on Monday. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The company has a market capitalization of $4.36 billion, a P/E ratio of 19.97, a price-to-earnings-growth ratio of 1.07 and a beta of 0.62. The company has a 50 day moving average of $120.70. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings data on Thursday, May 7th. The company reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a return on equity of 20.19% and a net margin of 12.26%.The company had revenue of $487.03 million during the quarter. During the same period in the previous year, the business earned $1.92 earnings per share. The business’s quarterly revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities research analysts anticipate that Adtalem Global Education Inc. will post 8.04 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Saturday. Truist Financial raised their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Finally, Zacks Research cut Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Adtalem Global Education has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.